MENU
+Compare
SMRI
ETF ticker: NASDAQ
AS OF
Sep 25 closing price
Price
$34.54
Change
-$0.26 (-0.75%)
Net Assets
470.65M

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Large Value
SMRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Sep 25, 2025

SMRI in +1.22% Uptrend, growing for three consecutive days on September 24, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SMRI advanced for three days, in of 141 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for SMRI crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 146 cases where SMRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SMRI moved out of overbought territory on September 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 27 cases where SMRI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SMRI as a result. In of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMRI turned negative on September 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 18 similar instances when the indicator turned negative. In of the 18 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMRI broke above its upper Bollinger Band on September 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Exxon Mobil Corp (NYSE:XOM), Chevron Corp (NYSE:CVX), Merck & Co (NYSE:MRK), QUALCOMM (NASDAQ:QCOM), Applied Materials (NASDAQ:AMAT), Amgen (NASDAQ:AMGN), ConocoPhillips (NYSE:COP), Nike (NYSE:NKE), Newmont Corp (NYSE:NEM), McKesson Corp (NYSE:MCK).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF ETF is 61.83B. The market cap for tickers in the group ranges from 10.26B to 492.79B. XOM holds the highest valuation in this group at 492.79B. The lowest valued company is MOH at 10.26B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF ETF was -0%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 12%. HAL experienced the highest price growth at 10%, while LEN experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was -8% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 43
Price Growth Rating: 43
SMR Rating: 51
Profit Risk Rating: 52
Seasonality Score: -12 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Fundamentals
Details
Category
Large Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com